Details for New Drug Application (NDA): 074562
✉ Email this page to a colleague
NDA 074562 describes LOCHOLEST LIGHT, which is a drug marketed by Chartwell Rx and is included in one NDA. It is available from one supplier. Additional details are available on the LOCHOLEST LIGHT profile page.
The generic ingredient in LOCHOLEST LIGHT is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
The generic ingredient in LOCHOLEST LIGHT is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for 074562
| Tradename: | LOCHOLEST LIGHT |
| Applicant: | Chartwell Rx |
| Ingredient: | cholestyramine |
| Patents: | 0 |
Pharmacology for NDA: 074562
| Mechanism of Action | Bile-acid Binding Activity |
Suppliers and Packaging for NDA: 074562
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LOCHOLEST LIGHT | cholestyramine | POWDER;ORAL | 074562 | ANDA | Chartwell RX, LLC | 62135-937 | 62135-937-54 | 239.4 g in 1 CAN (62135-937-54) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/PACKET | ||||
| Approval Date: | Aug 15, 1996 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/SCOOPFUL | ||||
| Approval Date: | Aug 15, 1996 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
